Structural insights into the agonist activity of the nonpeptide modulator JR14a on C3aR
Open Access
- 10 January 2025
- journal article
- letter
- Published by Springer Nature in Cell Discovery
- Vol. 11 (1) , 1-4
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Complement Receptors and Their Role in Leukocyte Recruitment and PhagocytosisFrontiers in Cell and Developmental Biology, 2021
- Potent Thiophene Antagonists of Human Complement C3a Receptor with Anti-Inflammatory ActivityJournal of Medicinal Chemistry, 2020
- Complement System Part I – Molecular Mechanisms of Activation and RegulationFrontiers in Immunology, 2015
- Complement System Part II: Role in ImmunityFrontiers in Immunology, 2015
- Potent Heterocyclic Ligands for Human Complement C3a ReceptorJournal of Medicinal Chemistry, 2014
- Complement: a key system for immune surveillance and homeostasisNature Immunology, 2010
- Persistent signaling induced by FTY720-phosphate is mediated by internalized S1P1 receptorsNature Chemical Biology, 2009
- The C3a receptor antagonist SB 290157 has agonist activityImmunology Letters, 2005
- Identification of a Selective Nonpeptide Antagonist of the Anaphylatoxin C3a Receptor That Demonstrates Antiinflammatory Activity in Animal ModelsThe Journal of Immunology, 2001
- C3a(desArg) does not bind to and signal through the human C3a receptorImmunology Letters, 1999